drugset / Trial / NCT07429643

Endoscopic Ultrasound-Guided Loco-regional Chemotherapy Injection as Adjuvant Therapy for Locally Advanced Pancreatic Cancer.

NCT07429643

Phase 2/3 Not yet recruiting 20 enrolled Assiut University
RandomizedParallel-groupOpen-labelTreatment

Summary

this is a randomized controlled trial aims to compare between patients with locally advanced pancreatic cancer treated with EUS-guided injection of gemcitabine in addition to systemic chemotherapy, versus those who treated with the standard systemic chemotherapy alone, regarding to(progression -free survival and response rate). Researchers will compare Arm A: patients received EUS-FNI of gemcitabine plus standard systemic chemotherapy to Arm B : patients receiving the standard systemic chemotherapy alone.

Timeline

Start
2026-04-15
Primary completion
2028-12-15
Completion
2028-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Gemcitabine Small molecule 200 mg/ml Other

Indications